CANTABRIA LABS is a Spanish pharmaceutical company specialising in dermatology. Its approach combines scientific research, clinically proven efficacy and proprietary patented technologies.
The company’s portfolio includes specialised ranges: HELIOCARE for comprehensive photoprotection, ENDOCARE for addressing signs of ageing, NEORETIN for pigmentation concerns, BIRETIX for acne-prone skin, SKIN RESIST for sensitive and reactive skin, and IRALTONE for hair and scalp health.
One of CANTABRIA LABS’ most significant scientific achievements is Fernblock® technology, developed in collaboration with Harvard Medical School, which has transformed the approach to protecting the skin from solar radiation.
